Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
- PMID: 17098083
- DOI: 10.1016/S0140-6736(06)69700-6
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
Abstract
Background: Cardiovascular mortality risk increases continuously with blood glucose, from concentrations well below conventional thresholds used to define diabetes. We aimed to quantify population-level effects of all higher-than-optimum concentrations of blood glucose on mortality from ischaemic heart disease and stroke worldwide.
Methods: We used population distribution of fasting plasma glucose to measure exposure to higher-than-optimum blood glucose. We collated exposure data in 52 countries from individual-level records in population health surveys, systematic reviews, and data provided by investigators. Relative risks for ischaemic heart disease and stroke mortality were from a meta-analysis of more than 200,000 participants in the Asia-Pacific region, with adjustment for other cardiovascular risk factors.
Results: In addition to 959,000 deaths directly assigned to diabetes, 1 490,000 deaths from ischaemic heart disease and 709,000 from stroke were attributable to high blood glucose, accounting for 21% and 13% of all deaths from these conditions. 1.8 million of these 2.2 million cardiovascular deaths (84%) were in low-and-middle-income countries (1,224,000 for ischaemic heart disease, 623,000 for stroke). 792,000 (53%) of deaths from ischaemic heart disease and 345,000 (49%) from stroke that were attributable to high blood glucose were in men. Largest numbers of deaths attributable to this risk factor from ischaemic heart disease were in low-and-middle-income countries of South Asia (548,000) and Europe and Central Asia (313,000), and from stroke in South Asia (215,000) and East Asia and Pacific (190,000).
Interpretation: Higher-than-optimum blood glucose is a leading cause of cardiovascular mortality in most world regions. Programmes for cardiovascular risk and diabetes management and control at the population level need to be more closely integrated.
Comment in
-
Blood glucose levels: facing a global crisis.Lancet. 2006 Nov 11;368(9548):1631-2. doi: 10.1016/S0140-6736(06)69675-X. Lancet. 2006. PMID: 17098065 No abstract available.
Similar articles
-
Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region.J Hypertens. 2007 Jan;25(1):73-9. doi: 10.1097/HJH.0b013e328010775f. J Hypertens. 2007. PMID: 17143176
-
The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions.Tob Control. 2006 Jun;15(3):181-8. doi: 10.1136/tc.2005.013284. Tob Control. 2006. PMID: 16728748 Free PMC article.
-
Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions.Asia Pac J Clin Nutr. 2007;16(1):187-92. Asia Pac J Clin Nutr. 2007. PMID: 17215197
-
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.Lancet Diabetes Endocrinol. 2014 Aug;2(8):634-47. doi: 10.1016/S2213-8587(14)70102-0. Epub 2014 May 16. Lancet Diabetes Endocrinol. 2014. PMID: 24842598 Free PMC article. Review.
-
Prognostic interactions between cardiovascular risk factors.Dan Med J. 2014 Jul;61(7):B4892. Dan Med J. 2014. PMID: 25123126 Review.
Cited by
-
Prognostic value of high-sensitivity cardiac troponin for major adverse cardiovascular events in patients with diabetes: a systematic review and meta-analysis.PeerJ. 2023 Nov 13;11:e16376. doi: 10.7717/peerj.16376. eCollection 2023. PeerJ. 2023. PMID: 38025710 Free PMC article.
-
Downregulation of CD151 restricts VCAM-1 mediated leukocyte infiltration to reduce neurobiological injuries after experimental stroke.J Neuroinflammation. 2021 May 22;18(1):118. doi: 10.1186/s12974-021-02171-6. J Neuroinflammation. 2021. PMID: 34022890 Free PMC article.
-
Approaches to prevention of cardiovascular complications and events in diabetes mellitus.Drugs. 2007;67(7):997-1026. doi: 10.2165/00003495-200767070-00005. Drugs. 2007. PMID: 17488145 Review.
-
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.Acta Diabetol. 2011 Dec;48(4):257-273. doi: 10.1007/s00592-011-0333-6. Epub 2011 Oct 2. Acta Diabetol. 2011. PMID: 21964884 Free PMC article. Review.
-
Impact of health workforce availability on health care seeking behavior of patients with diabetes mellitus in China.Int J Equity Health. 2017 Jul 1;16(1):80. doi: 10.1186/s12939-017-0576-0. Int J Equity Health. 2017. PMID: 28666449 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical